EcoDrugPlus

Protein Kinase C, Zeta

Ensembl ID : ENSPKIG00000014407
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSPKIG00000023242
Gene Symbol: PRKD3
2 Cross references
201 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSPKIG00000021379
Gene Symbol: PRKD3
3 Cross references
209 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSPKIG00000012565
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSPKIG00000000217
Gene Symbol: PPP3CA
4 Cross references
234 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSPKIG00000019417
Gene Symbol: PTK2
1 Cross references
164 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSPKIG00000014835
Gene Symbol: PTK2B
3 Cross references
200 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSPKIG00000004760
Gene Symbol: PTK6
3 Cross references
159 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSPKIG00000023620
Gene Symbol: PTPN11A
1 Cross references
249 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSPKIG00000022919
Gene Symbol: PTPRB
4 Cross references
201 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSPKIG00000022854
Gene Symbol: PTPRB
2 Cross references
201 Possible Orthologues:

Protein-Tyrosine Kinase 2-Beta-Like

Ensembl ID : ENSPKIG00000006792
Gene Symbol: LOC111841315
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).